Pharmacogenomics and Effective Treatment With Clopidogrel

Completed

Conditions studied: Pharmacogenomics and Cardiovascular Events

In brief

The aim of this biospecimen repository is to evaluate an individual's genotype, identify the variances, and understand how they relate to treatment with clopidogrel.

Key facts

Study ID

NCT01611545

Run by

Avera McKennan Hospital & University Health Center

People needed

130

Starts

2012-06-01

Expected to finish

2015-01-01

Last updated by the study team

2015-06-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Currently taking or prescribed Clopidogrel or under consideration
• Acute/interventionPatients of the Avera Heart Hospital
• Cardiology clinic patients with the Avera Heart Hospital and North Central Heart Institute

You may not qualify if…

• Unable to provide informed consent

Where it is running

• Avera Institute for Human Genetics — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.